Wie hoch ist der Preis für Faes Farma, S.A. (FAE)

Preis für Faes Farma, S.A. (FAE) ist $5.42

Wie hoch ist die Marktkapitalisierung für Faes Farma, S.A. (FAE)

Marktkapitalisierung für Faes Farma, S.A. (FAE) ist $1.69B

Faes Farma, S.A. (FAE) Dividenden

Faes Farma, S.A. is a pharmaceutical enterprise dedicated to the research, development, manufacture, and distribution of both finished medicinal products and crucial raw materials. Its extensive operations span Spain and a multitude of international markets. The company's comprehensive product line encompasses prescription drugs, generic alternatives, over-the-counter (OTC) remedies, nutritional supplements, infant formula, and various other health-related items. Among its diverse offerings are Actimag (a magnesium pidolate), the anti-allergic Bilaxten, the anti-infective Bronquidiazina CR, Claversal for ulcerative colitis and Crohn's disease, the corticoid Dezacor, the anti-inflammatory Dolotren (also available as Dolotren Gel), Dynamogen (an anti-anorexic), Ferroprotina (an anti-anaemic), Hidroferol, Lipofen, Positon for dermatological conditions, strength-enhancing products such as Potenciator and Surmenalit, the laxative Pruina, the muscle relaxant and analgesic Robaxisal Compuesto, Trausan (a citicoline-based product), the venous vasoprotector Venosmil (and Venosmil Gel), and the anti-influenza medication Yendol. Furthermore, Faes Farma provides key active pharmaceutical ingredients, including Bilastine (an antihistamine molecule for allergic rhinitis, conjunctivitis, and urticaria), Calcifediol for bone metabolism, Deflazacort for treating osteoarticular diseases, Hidrosmin for venous insufficiency, and Mesalazine for digestive problems. The firm also engages in significant export activities. Founded in 1933, Faes Farma, S.A. is headquartered in Leioa, Spain.

Jahr	Dividende (angepasst an Aktiensplits)	ändert
Nicht genügend Daten für die angegebenen Daten.

Jahr

Dividende (angepasst an Aktiensplits)

ändert

Nicht genügend Daten für die angegebenen Daten.

Jahr	Dividende	ändert
Nicht genügend Daten für die angegebenen Daten.

Jahr

Dividende

ändert

Nicht genügend Daten für die angegebenen Daten.

Unternehmen	Anzahl der Dividendenzahlungen	Land
MERCK Kommanditgesellschaft auf Aktien MER.SW	0.00%	DE
Merck KGaA MRK.DE	0.00%	DE
Takeda Pharmaceutical Company Limited 4502.T	0.00%	JP
Galderma Group AG GALD.SW	0.00%	CH
Sun Pharmaceutical Industries Limited SUNPHARMA.NS	38.00%	IN

Unternehmen

Anzahl der Dividendenzahlungen

Land